NASDAQ · PDEX

Pro – Dex Inc. New

$54.93 +$0.26 (+0.48%) 1D Market open
Charting by TradingView

Key Metrics

$174.55M
Market cap
14.54×
P/E · TTM
$74.64M
Revenue · TTM
$12.00M
Net income
EPS · TTM $3.63
Dividend yield —
Free cash flow —
Beta · 1Y 0.99
EBITDA · TTM $17.39M
Gross margin 27.8%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 5
    The stock moved +9.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 5

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$174.55M
Enterprise value—
Shares outstanding3.2M
52-wk range$23.47 – $68.99
Avg volume · 20D22.3K
Net cash —
Book value / share$13.69
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNASDAQ
About Pro – Dex Inc. New
IPO dateAug 7, 1986
Employees181

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E14.54
P/S2.34
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №$33.46

Profitability

Gross 27.8%
Operating 21.6%
Net 16.1%
FCF —
ROE / ROIC 31.6% · 31.9%

Financial Health

Current ratio3.67
Quick ratio2.14
Debt / equity—
Debt / EBITDA —
Net cash —
Working capital$39.07M

Cash Flow · TTM

Operating CF $7.34M
Capex —
Free cash flow —
Buybacks $2.81M
Dividends paid —
Shareholder yield 1.6%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

6.7
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$33.46 vs $54.93
Trades 1.6× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings